A sustained supply of exogenous IFNγ is effective in preventing the onset of AD in both murine AD models and human patients through modulation of the Th1/Th2 balance [5], implicating IFNγ as a critical target for therapeutic intervention in AD [1]. This evidence concerns the gene IFNG and Alzheimer disease.